These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 26699379
1. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations. Luk PP, Weston JD, Yu B, Selinger CI, Ekmejian R, Eviston TJ, Lum T, Gao K, Boyer M, O'Toole SA, Clark JR, Gupta R. Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379 [Abstract] [Full Text] [Related]
2. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes. Di Palma S, Simpson RH, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS. Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517 [Abstract] [Full Text] [Related]
3. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling. Gargano SM, Senarathne W, Feldman R, Florento E, Stafford P, Swensen J, Vranic S, Gatalica Z. Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094 [Abstract] [Full Text] [Related]
6. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE. Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294 [Abstract] [Full Text] [Related]
7. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma. Lubin D, Toorens E, Zhang PJ, Jaffer S, Baraban E, Bleiweiss IJ, Nayak A. Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929 [Abstract] [Full Text] [Related]
11. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland. Yamamoto H, Uryu H, Segawa Y, Tsuneyoshi M. Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833 [Abstract] [Full Text] [Related]
12. Clinicopathologic study of salivary duct carcinoma and the efficacy of androgen deprivation therapy. Yamamoto N, Minami S, Fujii M. Am J Otolaryngol; 2014 May; 35(6):731-5. PubMed ID: 25087467 [Abstract] [Full Text] [Related]
13. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma. Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim S. JAMA Otolaryngol Head Neck Surg; 2016 May 01; 142(5):489-95. PubMed ID: 26939990 [Abstract] [Full Text] [Related]
14. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis. Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Erber R, Iro H, Fietkau R, Agaimy A. Strahlenther Onkol; 2017 Nov 01; 193(11):961-970. PubMed ID: 28828496 [Abstract] [Full Text] [Related]
15. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE. Cancer; 2016 Oct 15; 122(20):3136-3144. PubMed ID: 27379604 [Abstract] [Full Text] [Related]